Medpace Holdings MEDP
NASDAQ MEDP
$616.67 +6.78 (+1.11%)
As of: Oct 14, 2026 · 2:06 PM EDT

Medpace Holdings (MEDP) Non-Current Deffered Revenue (2017 - 2018)

Updated

Medpace Holdings' Non-Current Deffered Revenue was $3.95 million in Q3 2018, down 81.1% from $20.96 million a year earlier and down 64.3% from the prior quarter.

Analysis

Medpace Holdings (MEDP) Non-Current Deffered Revenue (2017 - 2018) Analysis & Trends

At the end of FY2017, Non-Current Deffered Revenue at Medpace Holdings came in at $11.47 million.

  • Per Business Quant data, MEDP's Non-Current Deffered Revenue in the three quarters before Q3 2018 was $11.06 million (Q2 2018), $11.27 million (Q1 2018) and $11.47 million (Q4 2017).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Iqvia Holdings 43.61 Bn 35.31 Bn 1.44 Bn -
2 Medpace Holdings 17.34 Bn 15.40 Bn 201.64 Mn -
3 Charles River Laboratories International 14.63 Bn 13.82 Bn 363.37 Mn -
4 Icon 13.16 Bn 10.27 Bn 479.29 Mn -
5 Fortrea Holdings 2.02 Bn 1.40 Bn 139.20 Mn -
6 Ginkgo Bioworks Holdings 723.40 Mn -38.68 Mn 18.44 Mn 76.54 Mn
7 Evotec SE 502.55 Mn -1.11 Bn - 156.15 Mn
8 Champions Oncology 66.57 Mn 41.65 Mn 7.70 Mn -
9 MindWalk Holdings 63.08 Mn 26.73 Mn 1.61 Mn -
10 Natural Alternatives International 6.81 Mn -21.27 Mn 1.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 3.95 Mn
Jun 30, 2018 11.06 Mn
Mar 31, 2018 11.27 Mn
Dec 31, 2017 11.47 Mn
Sep 30, 2017 20.96 Mn
Jun 30, 2017 21.42 Mn
API Access

Medpace Holdings Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=MEDP&period=max&api_key=YOUR_API_KEY